Diabetes technology

During an 18‐month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range

Diabetes Obes MetabPublished Non-randomised, prospective, single-arm clinical trial

Authors' conclusion

Treatment with AID significantly increased TITR and TIR in young children. The positive effect of AID on glycaemic control observed after 6 months persisted throughout the 18 months of follow-up. Similarly, parental diabetes distress remained reduced during 18 months follow-up. These findings are reassuring and suggest that AID treatment improves glycaemic control and reduces parental diabetes distress in young children over an extended 18-month follow-up.

Study context

Population
Children aged 2 to 6 years treated with automated insulin delivery (AID), 2021–2023
Participants
35 children
Primary endpoint
Changes in TIR, HbA1c, TAR, TITR (3.9-7.8 mmol/L) and mean sensor glucose value
Follow-up
0, 6, 12 and 18 months
Methodological detailsnon-randomized, 18-month follow-up
  • Non-randomized
  • 18-month follow-up

Primary result

As reported in the abstract

TIR, TITR, HbA1c, mean sensor glucose, TAR · 0 to 6 months; through 18 months
Time in range (TIR) and time in tight range (TITR) increased, and HbA1c, mean sensor glucose and time above range (TAR) decreased significantly between 0 and 6 months
p < 0.001

Further findings

Parental diabetes distress (Problem Areas in Diabetes-Parent, revised (PAID-PR) score) · 0, 3 and 18 months

PAID-PR mean score at 0 months
37.5
PAID-PR mean score at 3 months
28.6 (p = 0.06)
PAID-PR mean score at 18 months
24.6 (p < 0.001)
PAID-PR score declined significantly between 3 and 18 months

Original publication

During an 18‐month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range. Diabetes Obes Metab. Published 21 March 2024. doi:10.1111/dom.15562

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.